Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides.

[1]  Arwin J. Brouwer,et al.  Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site. , 2014, Angewandte Chemie.

[2]  Younan Xia,et al.  Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry. , 2014, Angewandte Chemie.

[3]  M. Orio,et al.  A bio-inspired switch based on cobalt(II) disulfide/cobalt(III) thiolate interconversion. , 2014, Angewandte Chemie.

[4]  D. Boger,et al.  Design, Synthesis, and Characterization of α-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase , 2014, Journal of medicinal chemistry.

[5]  T. Muchamuel,et al.  Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis , 2014, EMBO molecular medicine.

[6]  Arwin J. Brouwer,et al.  Peptido sulfonyl fluorides as new powerful proteasome inhibitors. , 2012, Journal of medicinal chemistry.

[7]  Wenchao Gao,et al.  Recyclable hypervalent iodine(III) reagent iodosodilactone as an efficient coupling reagent for direct esterification, amidation, and peptide coupling. , 2012, Organic letters.

[8]  H. Overkleeft,et al.  Proteasome inhibitors: an expanding army attacking a unique target. , 2012, Chemistry & biology.

[9]  M. Groll,et al.  Exploiting nature's rich source of proteasome inhibitors as starting points in drug development. , 2012, Chemical communications.

[10]  Alejandro Criado,et al.  Inside Cover: [16]Cloverphene: a Clover‐Shaped cata‐Condensed Nanographene with Sixteen Fused Benzene Rings (Angew. Chem. Int. Ed. 1/2012) , 2012 .

[11]  L. Guterman,et al.  COVALENT DRUGS FORM LONG-LIVED TIES: IRREVERSIBLE INHIBITORS may provide unique benefits in drug development , 2011 .

[12]  David R. Bill,et al.  Aminodifluorosulfinium Salts: Selective Fluorination Reagents with Enhanced Thermal Stability and Ease of Handling, , 2010, The Journal of organic chemistry.

[13]  Khalid W. Kalim,et al.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.

[14]  S. Demo,et al.  Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. , 2007, Cancer research.

[15]  H. Overkleeft,et al.  Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors. , 2007, Organic & biomolecular chemistry.

[16]  K. Anderson,et al.  Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[17]  L. Dick,et al.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.

[18]  J. Hyatt,et al.  Chemistry of ethenesulfonyl fluoride. Fluorosulfonylethylation of organic compounds , 1979 .

[19]  E. V. Arx,et al.  Das 4,4′-tetramethyldiamino-diphenylmethan reagens (TDM) , 1976 .

[20]  W. E. Truce,et al.  .alpha.-Alkylation of alkyl alkanesulfonates , 1970 .